ESR2 and breast carcinoma: The antiproliferative action of the flavonoid apigenin in prostate and breast cancer cells is mediated by ERβ [57] as are the antiproliferative effects of soy isoflavones in colon cancer cells [58] and the phytoestrogen farrerol in vascular smooth muscle cells [59].